Omics-based strategies for improved diagnosis and treatment of endocrine hypertension (ENSAT-HT) is a large European grant ($12m total grant) that has been funded under the Horizon 2020 research initiative across Europe, with monies from PRESS made available through the NHMRC and investments by the University of Melbourne. PRESS are the primary software developers that are tasked with supporting all aspects of the clinical collaboration including the patient databases, the data linkage and sample management systems. This project builds upon the highly successful ENSAT-CANCER project (see below). The project runs to May 2020 and includes a major clinical trial involving over 4000 patients suffering from secondary hypertension.

Polycystic Ovarian Syndrome (PCOS) provides a secure, web-based registry for recording of clinical observations and treatments of patients with polycystic ovaries. This includes support for investigations and trials associated with these patients including use of physical biospecimens. The system also includes support for patient self-reporting through the targeted delivery of mobile applications (both iOS and Android applications) that allow patients to record their own patient reported information in advance of meeting with doctors in clinics. A range of hospitals and clinical centres in the UK is currently evaluating the system.